January 2024
1. PELC Z, Sedlak K, Mlak R, Chawrylak K, et al
   MalnutritiOn assessment with biOelectrical impedaNce analysis in gastRic cancer patIentS undergoing multimodaltrEatment (MOONRISE)-Study protocol for a single-arm multicenter cross-sectional longitudinal study.
   PLoS One. 2024;19:e0297583.
   

   >> Share

   
   
2. ZHANG H, Cheng X, Guo W, Zheng C, et al
   Metastasis patterns and prognosis in young gastric cancer patients: A propensity score?matched SEER database analysis.
   PLoS One. 2024;19:e0301834.
   

   >> Share

   
   January 2023
3. LIU W, Zhang F, Yang K, Yan Y, et al
   Comprehensive analysis regarding the prognostic significance of downregulated ferroptosis-related gene AKR1C2 in gastric cancer and its underlying roles in immune response.
   PLoS One. 2023;18:e0280989.
   

   >> Share

   
   
4. SHIN GY, Park JY, Lee SH, Cho YK, et al
   Tumor heterogeneity and carcinoma in resected specimens of gastric low-grade dysplasia: A retrospective single center study.
   PLoS One. 2023;18:e0280735.
   

   >> Share

   
   
5. ALARIDAH N, F Jarrar R, M Joudeh R, Aljarawen M, et al
   Knowledge and information sources towards Helicobacter pylori in Jordan.
   PLoS One. 2023;18:e0278078.
   

   >> Share

   
   
6. KODAMA M, Mizukami K, Hirashita Y, Okimoto T, et al
   Differences in clinical features and morphology between differentiated and undifferentiated gastric cancer after Helicobacter pylori eradication.
   PLoS One. 2023;18:e0282341.
   

   >> Share

   
   
7. 
   Retraction: MicroRNA-137 Contributes to Dampened Tumorigenesis in Human Gastric Cancer by Targeting AKT2.
   PLoS One. 2023;18:e0282977.
   

   >> Share

   
   
8. 
   Retraction: MicroRNA-219-2-3p Functions as a Tumor Suppressor in Gastric Cancer and Is Regulated by DNA Methylation.
   PLoS One. 2023;18:e0282980.
   

   >> Share

   
   
9. 
   Retraction: MicroRNA-10a Is Down-Regulated by DNA Methylation and Functions as a Tumor Suppressor in Gastric Cancer Cells.
   PLoS One. 2023;18:e0283120.
   

   >> Share

   
   
10. 
    Retraction: The MicroRNA-217 Functions as a Potential Tumor Suppressor in Gastric Cancer by Targeting GPC5.
    PLoS One. 2023;18:e0283151.
    

    >> Share

    
    
11. HU J, Cheng M, Li Y, Shi B, et al
    Ginseng-containing traditional medicine preparations in combination with fluoropyrimidine-based chemotherapy for advanced gastric cancer: A systematic review and meta-analysis.
    PLoS One. 2023;18:e0284398.
    

    >> Share

    
    
12. ZHENG C, Zhang Y, Cao J, Jing X, et al
    Survival benefits of perioperative chemoradiotherapy versus chemotherapy for advanced stage gastric cancer based on directed acyclic graphs.
    PLoS One. 2023;18:e0283854.
    

    >> Share

    
    
13. YOON K, Shin CM, Han K, Jung JH, et al
    Risk of cancer in patients with insomnia: Nationwide retrospective cohort study (2009-2018).
    PLoS One. 2023;18:e0284494.
    

    >> Share

    
    
14. OH SE, Choi MG, Lee JH, Sohn TS, et al
    Meso-jejunal lymph node dissection has a survival benefit in patients with remnant gastric cancer.
    PLoS One. 2023;18:e0285554.
    

    >> Share

    
    
15. RAWICZ-PRUSZYNSKI K, Sedlak K, Pelc Z, Mlak R, et al
    Staging LaParoscopy to Assess Lymph NOde InvoLvement in Advanced GAstric Cancer (POLA)-Study protocol for a single-arm prospective observational multicenter study.
    PLoS One. 2023;18:e0285758.
    

    >> Share

    
    
16. SOSSA-ROJAS H, Franco-Maz PG, Zapata-Acevedo C, Gutierrez-Castaneda LD, et al
    Preclinical evaluation of oncolytic potential human rotavirus Wt 1-5 in gastric adenocarcinoma.
    PLoS One. 2023;18:e0285543.
    

    >> Share

    
    
17. 
    Expression of Concern: HER3, but Not HER4, Plays an Essential Role in the Clinicopathology and Prognosis of Gastric Cancer: A Meta-Analysis.
    PLoS One. 2023;18:e0286446.
    

    >> Share

    
    
18. ABE A, Nakayama A, Otsuka Y, Shibata K, et al
    Relationship of preoperative oral hypofunction with prognostic nutritional index in gastric cancer: A case-control retrospective study.
    PLoS One. 2023;18:e0283911.
    

    >> Share

    
    
19. SEO JW, Park KB, Chin HM, Jun KH, et al
    Does Epstein-Barr virus-positive gastric cancer establish a significant relationship with the multiple genes related to gastric carcinogenesis?
    PLoS One. 2023;18:e0283366.
    

    >> Share

    
    
20. HONING J, Keith Tan W, Dieninyte E, O'Donovan M, et al
    Adequacy of endoscopic recognition and surveillance of gastric intestinal metaplasia and atrophic gastritis: A multicentre retrospective study in low incidence countries.
    PLoS One. 2023;18:e0287587.
    

    >> Share

    
    
21. MARIANI M, Pastorino R, Pires Marafon D, Johnson KC, et al
    Leisure-time physical activity and gastric cancer risk: A pooled study within the Stomach cancer Pooling (StoP) Project.
    PLoS One. 2023;18:e0286958.
    

    >> Share

    
    
22. XU S, Fan Y, Tan Y, Zhang L, et al
    Association between blood lipid levels and risk of gastric cancer: A systematic review and meta-analysis.
    PLoS One. 2023;18:e0288111.
    

    >> Share

    
    
23. HUANG Z, Yang H, Lao J, Deng W, et al
    Solute carrier family 35 member A2 (SLC35A2) is a prognostic biomarker and correlated with immune infiltration in stomach adenocarcinoma.
    PLoS One. 2023;18:e0287303.
    

    >> Share

    
    
24. HU Q, Xu J, Ke J, Zhang Z, et al
    S-1 and 5-Fluorouracil-related adverse events in patients with advanced gastric cancer: A meta-analysis.
    PLoS One. 2023;18:e0290003.
    

    >> Share

    
    
25. PARK H, Imoto S, Miyano S
    Comprehensive information-based differential gene regulatory networks analysis (CIdrgn): Application to gastric cancer and chemotherapy-responsive gene network identification.
    PLoS One. 2023;18:e0286044.
    

    >> Share

    
    
26. CHEN Y, Guo Y, Yuan M, Guo S, et al
    USP4 promotes the proliferation and glucose metabolism of gastric cancer cells by upregulating PKM2.
    PLoS One. 2023;18:e0290688.
    

    >> Share

    
    
27. KIATTIWEERASAK A, Bongkotvirawan P, Aumpan N, Yamaoka Y, et al
    Predictive factors and prognosis of upper gastrointestinal bleeding in gastric cancer: A large population-based study (UGIB-GC trial).
    PLoS One. 2023;18:e0291926.
    

    >> Share

    
    
28. MATSUSHITA A, Nakatani E, Shibasaki C, Tanabe S, et al
    Effectiveness of weight-loss prevention with continual nutrition counseling in postoperative outpatients with stage IA and IB gastric cancer.
    PLoS One. 2023;18:e0292920.
    

    >> Share

    
    
29. ZHANG YL, Wang YW, He MJ, Chang JL, et al
    An updated meta-analysis investigating the association between DNMTs gene polymorphism andgastric cancer risk.
    PLoS One. 2023;18:e0293466.
    

    >> Share

    
    
30. ZHANG Y, Qu L, Pan Y, Wu Y, et al
    Predictive value of hepatitis B serological indicators for mortality among cancer survivors and validation in a gastric cancer cohort.
    PLoS One. 2023;18:e0286441.
    

    >> Share

    
    January 2022
31. MORI T, Tanaka H, Deguchi S, Yamakoshi Y, et al
    Clinical efficacy of nivolumab is associated with tertiary lymphoid structures in surgically resected primary tumors of recurrent gastric cancer.
    PLoS One. 2022;17:e0262455.
    

    >> Share

    
    
32. IWASAKI K, Cho H, Maezawa Y, Tsuchida K, et al
    Assessment of the use of computed tomography colonography in early detection of peritoneal metastasis in patients with gastric cancer: A prospective cohort study.
    PLoS One. 2022;17:e0261527.
    

    >> Share

    
    
33. LEE HW, Huang D, Shin WK, de la Torre K, et al
    Obesity at early adulthood increases risk of gastric cancer from the Health Examinees-Gem (HEXA-G) study.
    PLoS One. 2022;17:e0260826.
    

    >> Share

    
    
34. SCHRUMPF T, Behrens HM, Haag J, Kruger S, et al
    FGFR2 overexpression and compromised survival in diffuse-type gastric cancer in a large central European cohort.
    PLoS One. 2022;17:e0264011.
    

    >> Share

    
    
35. NEMIDKANAM V, Chaichanawongsaroj N
    Characterizing Kaempferia parviflora extracellular vesicles, a nanomedicine candidate.
    PLoS One. 2022;17:e0262884.
    

    >> Share

    
    
36. 
    Retraction: Regulatory B Cell Function Is Suppressed by Smoking and Obesity in H. pylori-Infected Subjects and Is Correlated with Elevated Risk of Gastric Cancer.
    PLoS One. 2022;17:e0265376.
    

    >> Share

    
    
37. CHU J, Sun N, Hu W, Chen X, et al
    Bayesian hierarchical lasso Cox model: A 9-gene prognostic signature for overall survival in gastric cancer in an Asian population.
    PLoS One. 2022;17:e0266805.
    

    >> Share

    
    
38. ABDEL-TAWAB MS, Fouad H, Othman AM, Eid RA, et al
    Evaluation of gene expression of PLEKHS1, AADAC, and CDKN3 as novel genomic markers in gastric carcinoma.
    PLoS One. 2022;17:e0265184.
    

    >> Share

    
    
39. HU G, Wang S, Wang S, Huang L, et al
    Elevated baseline circulating platelet-to-lymphocyte ratio and survival in initial stage gastric cancer patients: A meta-analysis.
    PLoS One. 2022;17:e0265897.
    

    >> Share

    
    
40. YANG S, Gu X, Tao R, Huo J, et al
    Relationship between histological mixed-type early gastric cancer and lymph node metastasis: A systematic review and meta-analysis.
    PLoS One. 2022;17:e0266952.
    

    >> Share

    
    
41. GE H, Yan Y, Tian F, Guo L, et al
    LINC00922 promotes deterioration of gastric cancer.
    PLoS One. 2022;17:e0267798.
    

    >> Share

    
    
42. WANG L, Yin D, Fan Y, Min T, et al
    Molecular mechanism of the anti-gastric cancer activity of 1,2,3,6-tetra-O-galloyl-beta-D-glucose isolated from Trapa bispinosa Roxb. shell in vitro.
    PLoS One. 2022;17:e0269013.
    

    >> Share

    
    
43. COSTA AC, Santa-Cruz F, Araujo RLC, Leitao G, et al
    Analysis of cathepsin S expression in gastric adenocarcinoma and in Helicobacter pylori infection.
    PLoS One. 2022;17:e0268836.
    

    >> Share

    
    
44. 
    Retraction: MicroRNA-410 Suppresses Migration and Invasion by Targeting MDM2 in Gastric Cancer.
    PLoS One. 2022;17:e0269898.
    

    >> Share

    
    
45. 
    Retraction: Prognostic and clinicopathological significance of C-reactive protein/albumin ratio (CAR) in patients with gastric cancer: A meta-analysis.
    PLoS One. 2022;17:e0270727.
    

    >> Share

    
    
46. 
    Retraction: ALDH2 and ADH1 Genetic Polymorphisms May Contribute to the Risk of Gastric Cancer: A Meta-Analysis.
    PLoS One. 2022;17:e0270613.
    

    >> Share

    
    
47. XU MQ, Sun K, Cao C, Yin HH, et al
    Age-related twin-peak prevalence profiles of H. pylori infection, gastritis, GIN and gastric cancer: Analyses of 70,534 patients with gastroscopic biopsies.
    PLoS One. 2022;17:e0265885.
    

    >> Share

    
    
48. RIGTER LS, Snaebjornsson P, Rosenberg EH, Altena E, et al
    Molecular characterization of gastric adenocarcinoma diagnosed in patients previously treated for Hodgkin lymphoma or testicular cancer.
    PLoS One. 2022;17:e0270591.
    

    >> Share

    
    
49. GURNEY J, Whitehead J, Kerrison C, Stanley J, et al
    Equity of travel required to access first definitive surgery for liver or stomach cancer in New Zealand.
    PLoS One. 2022;17:e0269593.
    

    >> Share

    
    
50. 
    Expression of Concern: Clinicopathological Significance and Prognostic Value of Lactate Dehydrogenase A Expression in Gastric Cancer Patients.
    PLoS One. 2022;17:e0273730.
    

    >> Share

    
    
51. KAJIWARA SAITO M, Morishima T, Ma C, Koyama S, et al
    Diagnosis and treatment of digestive cancers during COVID-19 in Japan: A Cancer Registry-based Study on the Impact of COVID-19 on Cancer Care in Osaka (CanReCO).
    PLoS One. 2022;17:e0274918.
    

    >> Share

    
    
52. 
    Retraction: IL-26 Promotes the Proliferation and Survival of Human Gastric Cancer Cells by Regulating the Balance of STAT1 and STAT3 Activation.
    PLoS One. 2022;17:e0274980.
    

    >> Share

    
    
53. WANG Q, Chen Y, Peng Y, Yuan H, et al
    Preferences of oral nutritional supplement therapy among postoperative patients with gastric cancer: Attributes development for a discrete choice experiment.
    PLoS One. 2022;17:e0275209.
    

    >> Share

    
    
54. HERNG SC, Htet NH, Naing C
    A comparison of neoadjuvant therapies for gastroesophageal and gastric cancer on tumour resection rate: A network meta-analysis.
    PLoS One. 2022;17:e0275186.
    

    >> Share

    
    
55. SHAH MA, Wainberg ZA, Catenacci DVT, Hochster HS, et al
    Correction: Phase II Study Evaluating 2 Dosing Schedules of Oral Foretinib (GSK1363089), cMET/VEGFR2 Inhibitor, in Patients with Metastatic Gastric Cancer.
    PLoS One. 2022;17:e0276211.
    

    >> Share

    
    
56. 
    Correction: Correction: Phase II Study Evaluating 2 Dosing Schedules of Oral Foretinib (GSK1363089), cMET/VEGFR2 Inhibitor, in Patients with Metastatic Gastric Cancer.
    PLoS One. 2022;17:e0276650.
    

    >> Share

    
    
57. DONDOV G, Amarbayasgalan D, Batsaikhan B, Badamjav T, et al
    Diagnostic performances of pepsinogens and gastrin-17 for atrophic gastritis and gastric cancer in Mongolian subjects.
    PLoS One. 2022;17:e0274938.
    

    >> Share

    
    
58. LI XN, Peng YH, Yue W, Tao L, et al
    A cohort study using IL-6/Stat3 activity and PD-1/PD-L1 expression to predict five-year survival for patients after gastric cancer resection.
    PLoS One. 2022;17:e0277908.
    

    >> Share

    
    
59. KIM HJ, Yoon HM, Ryu KW, Kim YW, et al
    An early interactive human coaching via a mobile application to improve quality of life in patients who underwent gastrectomy for gastric cancer: Design and protocol of a randomized controlled trial.
    PLoS One. 2022;17:e0278370.
    

    >> Share

    
    
60. BARMPOUTIS P, Waddingham W, Yuan J, Ross C, et al
    A digital pathology workflow for the segmentation and classification of gastric glands: Study of gastric atrophy and intestinal metaplasia cases.
    PLoS One. 2022;17:e0275232.
    

    >> Share

    
    January 2021
61. HUANG SC, Ng KF, Chang IY, Chang CJ, et al
    The clinicopathological significance of SWI/SNF alterations in gastric cancer is associated with the molecular subtypes.
    PLoS One. 2021;16:e0245356.
    

    >> Share

    
    
62. TOKUYAMA N, Takegawa N, Nishikawa M, Sakai A, et al
    Pretreatment Glasgow prognostic score as a predictor of outcomes in nivolumab-treated patients with advanced gastric cancer.
    PLoS One. 2021;16:e0247645.
    

    >> Share

    
    
63. KUMAMOTO T, Sasako M, Ishida Y, Kurahashi Y, et al
    Clinical outcomes of proximal gastrectomy for gastric cancer: A comparison between the double-flap technique and jejunal interposition.
    PLoS One. 2021;16:e0247636.
    

    >> Share

    
    
64. NODA H, Kaise M, Wada R, Koizumi E, et al
    Characteristics of non-neoplastic epithelium that appears within gastric cancer with and without Helicobacter pylori eradication: A retrospective study.
    PLoS One. 2021;16:e0248333.
    

    >> Share

    
    
65. MIN KW, Kim DH, Son BK, Moon KM, et al
    High SLC2A1 expression associated with suppressing CD8 T cells and B cells promoted cancer survival in gastric cancer.
    PLoS One. 2021;16:e0245075.
    

    >> Share

    
    
66. SAKURAI K, Kubo N, Tamamori Y, Aomatsu N, et al
    Impact of chronic kidney disease on the short- and long-term outcomes of laparoscopic gastrectomy for gastric cancer patients.
    PLoS One. 2021;16:e0250997.
    

    >> Share

    
    
67. WANG Z, Liu C
    Upregulated hsa_circRNA_100269 inhibits the growth and metastasis of gastric cancer through inactivating PI3K/Akt axis.
    PLoS One. 2021;16:e0250603.
    

    >> Share

    
    
68. YU J, Liu H, Zeng X, Zhao Y, et al
    Prognostic and clinicopathological significance of C-reactive protein/albumin ratio (CAR) in patients with gastric cancer: A meta-analysis.
    PLoS One. 2021;16:e0250295.
    

    >> Share

    
    
69. JANG A, Jeong O
    Intolerability to postoperative early oral nutrition in older patients (>/=70 years) undergoing gastrectomy for gastric cancer: A case-control study.
    PLoS One. 2021;16:e0251844.
    

    >> Share

    
    
70. SUH KJ, Kim JW, Kim JE, Sung JH, et al
    Correlation between tumor infiltrating immune cells and peripheral regulatory T cell determined using methylation analyses and its prognostic significance in resected gastric cancer.
    PLoS One. 2021;16:e0252480.
    

    >> Share

    
    
71. FAKANYE O, Singh H, Desautels D, Torabi M, et al
    Geographical variation and factors associated with gastric cancer in Manitoba.
    PLoS One. 2021;16:e0253650.
    

    >> Share

    
    
72. SUGIMOTO A, Okuno T, Tsujio G, Sera T, et al
    The clinicopathologic significance of Tks5 expression of peritoneal mesothelial cells in gastric cancer patients.
    PLoS One. 2021;16:e0253702.
    

    >> Share

    
    
73. LIU G, Ma JY, Hu G, Jin H, et al
    Identification and validation of a novel ferroptosis-related gene model for predicting the prognosis of gastric cancer patients.
    PLoS One. 2021;16:e0254368.
    

    >> Share

    
    
74. WALLANDER K, Eisfeldt J, Lindblad M, Nilsson D, et al
    Cell-free tumour DNA analysis detects copy number alterations in gastro-oesophageal cancer patients.
    PLoS One. 2021;16:e0245488.
    

    >> Share

    
    
75. KANG DY, Kim HG, Kim DY
    Reduced-port laparoscopic distal gastrectomy in obese gastric cancer patients.
    PLoS One. 2021;16:e0255855.
    

    >> Share

    
    
76. BASAK D, Jamal Z, Ghosh A, Mondal PK, et al
    Reciprocal interplay between asporin and decorin: Implications in gastric cancer prognosis.
    PLoS One. 2021;16:e0255915.
    

    >> Share

    
    
77. AUMPAN N, Vilaichone RK, Pornthisarn B, Chonprasertsuk S, et al
    Predictors for regression and progression of intestinal metaplasia (IM): A large population-based study from low prevalence area of gastric cancer (IM-predictor trial).
    PLoS One. 2021;16:e0255601.
    

    >> Share

    
    
78. SAKURAI K, Kubo N, Tamamori Y, Aomatsu N, et al
    Depletion of skeletal muscle mass adversely affects long-term outcomes for men undergoing gastrectomy for gastric cancer.
    PLoS One. 2021;16:e0256365.
    

    >> Share

    
    
79. GORNOWICZ A, Szymanowski W, Czarnomysy R, Bielawski K, et al
    Anti-HER2 monoclonal antibodies intensify the susceptibility of human gastric cancer cells to etoposide by promoting apoptosis, but not autophagy.
    PLoS One. 2021;16:e0255585.
    

    >> Share

    
    
80. ABE H, Kunita A, Otake Y, Kanda T, et al
    Virus-host interactions in carcinogenesis of Epstein-Barr virus-associated gastric carcinoma: Potential roles of lost ARID1A expression in its early stage.
    PLoS One. 2021;16:e0256440.
    

    >> Share

    
    
81. RYU KW, Bae JM, Kim EM, An JY, et al
    Long-term effect of simplified dietary education on the nutritional status of patients after a gastrectomy.
    PLoS One. 2021;16:e0252168.
    

    >> Share

    
    
82. SHAH MA, Wainberg ZA, Catenacci DVT, Hochster HS, et al
    Correction: Phase II Study Evaluating 2 Dosing Schedules of Oral Foretinib (GSK1363089), cMET/VEGFR2 Inhibitor, in Patients with Metastatic Gastric Cancer.
    PLoS One. 2021;16:e0261994.
    

    >> Share

    
    
83. HARADA H, Nie Y, Araki I, Soeno T, et al
    Haploinsufficiency by minute MutL homolog 1 promoter DNA methylation may represent unique phenotypes of microsatellite instability-gastric carcinogenesis.
    PLoS One. 2021;16:e0260303.
    

    >> Share

    
    
84. HODGES P, Kelly P, Kayamba V
    Helicobacter pylori infection and hypochlorhydria in Zambian adults and children: A secondary data analysis.
    PLoS One. 2021;16:e0256487.
    

    >> Share

    
    
85. WEI G, Dong Y, He Z, Qiu H, et al
    Identification of hub genes and construction of an mRNA-miRNA-lncRNA network of gastric carcinoma using integrated bioinformatics analysis.
    PLoS One. 2021;16:e0261728.
    

    >> Share

    
    
86. ALKHAFFAF B, Metryka A, Blazeby JM, Glenny AM, et al
    How are trial outcomes prioritised by stakeholders from different regions? Analysis of an international Delphi survey to develop a core outcome set in gastric cancer surgery.
    PLoS One. 2021;16:e0261937.
    

    >> Share

    
    January 2020
87. AUMPAN N, Vilaichone RK, Nunanan P, Chonprasertsuk S, et al
    Predictors for development of complete and incomplete intestinal metaplasia (IM) associated with H. pylori infection: A large-scale study from low prevalence area of gastric cancer (IM-HP trial).
    PLoS One. 2020;15:e0239434.
    

    >> Share

    
    
88. BANG S, Kim H, Jang K, Paik SS, et al
    The loss of nuclear expression of single-stranded DNA binding protein 2 of gastric adenocarcinoma and its prognostic role: Analysis of molecular subtype.
    PLoS One. 2020;15:e0236896.
    

    >> Share

    
    
89. SASAKI N, Iwaya T, Chiba T, Fujita M, et al
    Analysis of mutational and proteomic heterogeneity of gastric cancer suggests an effective pipeline to monitor post-treatment tumor burden using circulating tumor DNA.
    PLoS One. 2020;15:e0239966.
    

    >> Share

    
    
90. HU Q, Masuda T, Kuramitsu S, Tobo T, et al
    Potential association of LOXL1 with peritoneal dissemination in gastric cancer possibly via promotion of EMT.
    PLoS One. 2020;15:e0241140.
    

    >> Share

    
    
91. ZHAO C, Feng Z, He H, Zang D, et al
    Protein expression-based classification of gastric cancer by immunohistochemistry of tissue microarray.
    PLoS One. 2020;15:e0238836.
    

    >> Share

    
    
92. 
    Retraction: Decreased miR-204 in H. pylori-Associated Gastric Cancer Promotes Cancer Cell Proliferation and Invasion by Targeting SOX4.
    PLoS One. 2020;15:e0241451.
    

    >> Share

    
    
93. SANIKINI H, Muller DC, Chadeau-Hyam M, Murphy N, et al
    Anthropometry, body fat composition and reproductive factors and risk of oesophageal and gastric cancer by subtype and subsite in the UK Biobank cohort.
    PLoS One. 2020;15:e0240413.
    

    >> Share

    
    
94. ZOU Q, Zhang H, Meng F, He L, et al
    Proteomic and transcriptomic studies of BGC823 cells stimulated with Helicobacter pylori isolates from gastric MALT lymphoma.
    PLoS One. 2020;15:e0238379.
    

    >> Share

    
    
95. KANG HJ, Lee HH, Jung SE, Park KS, et al
    Pattern of failure and optimal treatment strategy for primary gastric diffuse large B-cell lymphoma treated with R-CHOP chemotherapy.
    PLoS One. 2020;15:e0238807.
    

    >> Share

    
    
96. TSUMURA T, Kuroda S, Nishizaki M, Kikuchi S, et al
    Short-term and long-term comparisons of laparoscopy-assisted proximal gastrectomy with esophagogastrostomy by the double-flap technique and laparoscopy-assisted total gastrectomy for proximal gastric cancer.
    PLoS One. 2020;15:e0242223.
    

    >> Share

    
    
97. BU J, Lee TH, Jeong WJ, Poellmann MJ, et al
    Enhanced detection of cell-free DNA (cfDNA) enables its use as a reliable biomarker for diagnosis and prognosis of gastric cancer.
    PLoS One. 2020;15:e0242145.
    

    >> Share

    
    
98. 
    Retraction: Aberrant CCR4 Expression Is Involved in Tumor Invasion of Lymph Node-Negative Human Gastric Cancer.
    PLoS One. 2020;15:e0244287.
    

    >> Share

    
    
99. ZHU SL, Dong J, Zhang C, Huang YB, et al
    Application of machine learning in the diagnosis of gastric cancer based on noninvasive characteristics.
    PLoS One. 2020;15:e0244869.
    

    >> Share

    
    
100. ALI AS, Langer SW, Federspiel B, Hjortland GO, et al
     PD-L1 expression in gastroenteropancreatic neuroendocrine neoplasms grade 3.
     PLoS One. 2020;15:e0243900.
     

     >> Share

     
     
101. TOYODA Y, Tabuchi T, Hama H, Morishima T, et al
     Trends in clinical stage distribution and screening detection of cancer in Osaka, Japan: Stomach, colorectum, lung, breast and cervix.
     PLoS One. 2020;15:e0244644.
     

     >> Share

     
     

Free Medical Abstracts
Privacy Policy
Sponsors
Share